Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction
- PMID: 16360345
- DOI: 10.1016/j.amjcard.2005.07.076
Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction
Abstract
In a retrospective study of 36 patients who developed cardiogenic shock after myocardial infarction, intravenous vasopressin therapy increased mean arterial pressure from 56 to 73 mm Hg at 1 hour (p < 0.001) and maintained it for 24 hours without changing pulmonary capillary wedge pressure, cardiac index, urine output, or other inotropic requirements. After norepinephrine administration, mean pulmonary capillary wedge pressure increased at 1 hour from 21 to 24 mm Hg (p = 0.04); however, this increase was not sustained at 12 and 24 hours. Norepinephrine was associated with a significant increase in cardiac power index at 24 hours, whereas there was only a trend for an increase in cardiac power with vasopressin therapy. In a cohort of patients who developed refractory cardiogenic shock after myocardial infarction, vasopressin was associated with increased mean arterial pressure and no adverse effect on other hemodynamic parameters.
Similar articles
-
Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.Acute Card Care. 2009;11(2):99-106. doi: 10.1080/17482940902807286. Acute Card Care. 2009. PMID: 19353405
-
Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.Crit Care Med. 2009 Dec;37(12):3017-23. doi: 10.1097/CCM.0b013e3181b0314a. Crit Care Med. 2009. PMID: 19661807
-
Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration.Can J Cardiol. 1995 Jan;11(1):30-6. Can J Cardiol. 1995. PMID: 7850662 Clinical Trial.
-
Pharmacologic support in cardiogenic shock.Adv Shock Res. 1983;10:35-49. Adv Shock Res. 1983. PMID: 6349299 Review.
-
["Cardiac power output" an old tool, possibly a modern tool for assessing cardiac pumping capability, as well as for a short-term prognosis in cardiogenic shock due to acute myocardial infarction].Arch Cardiol Mex. 2006 Jan-Mar;76(1):95-108. Arch Cardiol Mex. 2006. PMID: 16749510 Review. Spanish.
Cited by
-
Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?Crit Care. 2009;13(4):169. doi: 10.1186/cc7954. Epub 2009 Jul 22. Crit Care. 2009. PMID: 19664189 Free PMC article.
-
Management of cardiogenic shock complicating acute myocardial infarction: A review.Clin Cardiol. 2019 Apr;42(4):484-493. doi: 10.1002/clc.23168. Epub 2019 Mar 27. Clin Cardiol. 2019. PMID: 30815887 Free PMC article. Review.
-
Time-sensitive approach in the management of acute heart failure.ESC Heart Fail. 2021 Feb;8(1):204-221. doi: 10.1002/ehf2.13139. Epub 2020 Dec 9. ESC Heart Fail. 2021. PMID: 33295126 Free PMC article. Review.
-
[Cardiogenic shock].Herz. 2013 Mar;38(2):173-86; quiz 187-8. doi: 10.1007/s00059-013-3770-x. Herz. 2013. PMID: 23471359 German.
-
[Cardiogenic shock].Anaesthesist. 2012 Mar;61(3):259-72; quiz 273-4. doi: 10.1007/s00101-012-1986-4. Anaesthesist. 2012. PMID: 22430557 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources